The PhRMA API Technical Group examines topics concerning active pharmaceutical ingredient development and manufacture and makes recommendations for regulatory guidance.
Michael Mitchell
Advertisement
Michael Mitchell is vice-president of chemical development at Schering-Plough Research Institute.
Articles by Michael Mitchell
Advertisement
Latest Updated Articles
- PhRMA Perspectives on Drug Substance Regulatory Filing Issues
Published: February 2nd 2003 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
